BIO-Europe Press Releases

November 10, 2009 BIO-Europe 2009 Sets New Record for Attendance and Partnering Productivity Leaders from the biotechnology and pharmaceutical industries gathered last week at the Vienna Messe for the 15th annual BIO-Europe partnering conference. The conference drew 2,500 delegates, representing 1,400 companies from 50 countries, who in engaged in 12,504 one-to-one partnering meetings. In addition, there were 22 workshops and panel sessions, and 170 presentations by biotech companies seeking financing, licensing opportunities or partners for advancing their product development. more ►

October 19, 2009 BIO-Europe 2009 Announces Program Highlights Less than two weeks remains before BIO-Europe 2009, the world’s largest stand-alone partnering conference, takes place in Vienna, Austria on November 2–4. In response to the continuous growth and popularity of this well established biotechnology partnering event, EBD Group is announcing additional conference program highlights to offer even greater insight into a variety of important industry topics. more ►

October 9, 2009 BIO-Europe 2009: World’s Leading Biotech Companies, Pharmaceutical Firms and Financiers
Get Ready for Three Days of Intense Partnering in Vienna
With partnering deals still driving drug development markets, this year’s BIO-Europe conference is set to establish new standards for generating quality partnering meetings and providing the insights needed to successfully operate in an era of dramatic biotech industry change. Many of the most respected industry thought leaders and decision makers will once again travel to BIO-Europe to examine the issues, new business approaches and policy trends that are vital to biotech’s successful long term future. To date, there are already 2,002 licensing opportunities, an impressive 1,170 companies from 46 countries registered, and over 2,000 delegates actively booking one-to-one meetings. more ►

September 22, 2009 Top 20 Pharma Firms to Hunt for Deals at BIO-Europe 2009 In order to seek out new partnering opportunities, the top 20 big pharma companies will be in attendance on November 2–4 in Vienna, Austria for BIO-Europe 2009, the  largest dedicated partnering conference in Europe. Teams of scouts from the likes of Abbott, Amgen, Astellas Pharma, AstraZeneca, Baxter, Bayer HealthCare/Bayer Schering Pharma, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, Genentech, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Merck Serono, Novartis, Pfizer, Roche, Sanofi Aventis, Takeda Pharmaceutical Co., Teva Pharmaceutical Industries will attend the conference to examine industry issues, learn new business approaches, and most importantly, network with biotechs and other organizations toward successful business deals.more ►

BIO-Europe previous press releases ►


partneringONE

Latest headlines from partneringNEWS®

Visit partneringNEWS »


© 2009–2010 EBD Group AG
BioEurope 2010 EBD GroupBIO